» Articles » PMID: 33081616

The Evolution of Virulence in During Chronic Wound Infection

Overview
Journal Proc Biol Sci
Specialty Biology
Date 2020 Oct 21
PMID 33081616
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Opportunistic pathogens are associated with a number of chronic human infections, yet the evolution of virulence in these organisms during chronic infection remains poorly understood. Here, we tested the evolution of virulence in the human opportunistic pathogen in a murine chronic wound model using a two-part serial passage and sepsis experiment, and found that virulence evolved in different directions in each line of evolution. We also assessed adaptation to a chronic wound after 42 days of evolution and found that morphological diversity in our evolved populations was limited compared with that previously described in cystic fibrosis (CF) infections. Using whole-genome sequencing, we found that genes previously implicated in pathogenesis (, , , and ) contained mutations during the course of evolution in wounds, with selection occurring in parallel across all lines of evolution. Our findings highlight that: (i) heterogeneity may be less extensive in chronic wounds than in CF lungs; (ii) genes involved in pathogenesis acquire mutations during chronic wound infection; (iii) similar genetic adaptations are employed by across multiple infection environments; and (iv) current models of virulence may not adequately explain the diverging evolutionary trajectories observed in an opportunistic pathogen during chronic wound infection.

Citing Articles

Chronic wounds and adaptive : A phenotypic and genotypic characterization.

Buchholtz K, Jonsson R, Marvig R, Mojsoska B, Krogfelt K Curr Res Microb Sci. 2025; 8:100348.

PMID: 40027448 PMC: 11868952. DOI: 10.1016/j.crmicr.2025.100348.


Comparative analysis of virulence factors produced by strains isolated from chronic wounds or bloodstream infections.

Teixeira F, Pauer H, Valente G, de Paula G MicroPubl Biol. 2025; 2024.

PMID: 39748833 PMC: 11688615. DOI: 10.17912/micropub.biology.001413.


Antibiotics-encapsulated nanoparticles as an antimicrobial agent in the treatment of wound infection.

Taheri M, Arabestani M, Kalhori F, Asl S, Asgari M, Hosseini S Front Immunol. 2024; 15:1435151.

PMID: 39534603 PMC: 11554516. DOI: 10.3389/fimmu.2024.1435151.


A Standardized Mouse Model for Wound Infection with .

Hou J, Wu Q, Xiong R, Malakar P, Zhu Y, Zhao Y Int J Mol Sci. 2024; 25(21).

PMID: 39519323 PMC: 11546588. DOI: 10.3390/ijms252111773.


3D printed personalized wound dressings using a hydrophobic deep eutectic solvent (HDES)-formulated emulgel.

Yusakul G, Jomrit J, Bacabac R, Prasopthum A RSC Adv. 2024; 14(46):34175-34191.

PMID: 39469022 PMC: 11513773. DOI: 10.1039/d4ra05456c.


References
1.
Rumbaugh K, Trivedi U, Watters C, Burton-Chellew M, Diggle S, West S . Kin selection, quorum sensing and virulence in pathogenic bacteria. Proc Biol Sci. 2012; 279(1742):3584-8. PMC: 3396913. DOI: 10.1098/rspb.2012.0843. View

2.
Serra R, Grande R, Butrico L, Rossi A, Settimio U, Caroleo B . Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus. Expert Rev Anti Infect Ther. 2015; 13(5):605-13. DOI: 10.1586/14787210.2015.1023291. View

3.
Workentine M, Sibley C, Glezerson B, Purighalla S, Norgaard-Gron J, Parkins M . Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLoS One. 2013; 8(4):e60225. PMC: 3616088. DOI: 10.1371/journal.pone.0060225. View

4.
Guest J, Ayoub N, McIlwraith T, Uchegbu I, Gerrish A, Weidlich D . Health economic burden that different wound types impose on the UK's National Health Service. Int Wound J. 2016; 14(2):322-330. PMC: 7950097. DOI: 10.1111/iwj.12603. View

5.
Totten P, Lara J, Lory S . The rpoN gene product of Pseudomonas aeruginosa is required for expression of diverse genes, including the flagellin gene. J Bacteriol. 1990; 172(1):389-96. PMC: 208444. DOI: 10.1128/jb.172.1.389-396.1990. View